Stock listing
NASDAQ:ALDR Alder BioPharmaceuticals Inc Stock
Follow Alder BioPharmaceuticals Inc into a list and get an email when it puts out news.
Last close · NASDAQ:ALDR
$18.88 USD
Close on Oct 21, 2019 · No longer trades
- Lowest – highest close
- $8.59 – $52.97 USDSince May 8, 2014 · lowest Sep 3, 2019 · highest Jun 30, 2015
Delisted NASDAQ:ALDR no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:ALDR
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Robert Azelby Other companies: Tango Therapeutics, Inc. (Chairman; Former President and CEO, Eliem Therapeutics, Inc. · Since at least Jun 19, 2026); Autolus Therapeutics plc (Director · Since at least Mar 18, 2026); Terns Pharmaceuticals, Inc. (Director · Since at least Feb 20, 2025); Cardinal Health, Inc. (Director · Since at least Mar 1, 2024); ADC Therapeutics SA (Director · Since at least Jan 2, 2024); Aduro Biotech Inc (Director · Apr 10, 2023 – Aug 11, 2023 · Past); Climb Bio, Inc. (President & CEO, Director · Aug 9, 2021 – Oct 31, 2022 · Past); Immunomedics Inc (Director · Feb 26, 2020 – Oct 23, 2020 · Past); Clovis Oncology Inc (Director · Oct 11, 2018 – Jun 10, 2021 · Past); Cascadian Therapeutics Inc (Director · Mar 31, 2017 – Mar 9, 2018 · Past); Juno Therapeutics Inc (EVP & Chief Commercial Officer · Nov 1, 2015 – Mar 5, 2018 · Past) | President and CEO, Director · Jun 13, 2018 – Oct 22, 2019 · Past |
| Erin Lavelle Other companies: Avalyn Pharma Inc. (Director · Since at least Apr 29, 2026); Jade Biosciences, Inc. (Director · Since at least Apr 28, 2025); Neurogene Inc. (Director · May 12, 2022 – Jun 8, 2023 · Past); Climb Bio, Inc. (COO & CFO · Aug 9, 2021 – Oct 31, 2022 · Past) | Chief Operating Officer · Apr 16, 2018 – Oct 22, 2019 · Past |
| Paul Carter Other companies: Immatics N.V. (Non-Executive Director · Since at least Mar 18, 2026); Mallinckrodt Inc (Director · May 16, 2018 – Jun 16, 2022 · Past); Gilead Sciences, Inc. (EVP Commercial Ops · Jul 1, 2015 – Aug 1, 2016 · Past) | Director · Sep 28, 2015 – Oct 22, 2019 · Past |
| Alan Bruce Montgomery Other companies: Xencor, Inc. (Director · Since at least Jun 23, 2016); CytoDyn Inc. (Director · Jun 1, 2016 – Jul 12, 2018 · Past) | Director · May 26, 2016 – Oct 22, 2019 · Past |
| Jeffrey T L Smith Other companies: Zymeworks Inc. (EVP & Chief Medical Officer · Since at least Jan 3, 2024) | Managing Director · Dec 14, 2017 – Oct 22, 2019 · Past |
| Aaron Davidson | Director · May 7, 2014 – May 13, 2014 · Past |
| John A Latham | Chief Scientific Officer · May 7, 2014 – Feb 6, 2019 · Past |
| Timothy M Whitaker | Chief Medical Officer · Jun 20, 2016 – Jan 27, 2017 · Past |
Log in to ask 6ix AI your own questions about Alder BioPharmaceuticals Inc.